Posts from Archives: Press Releases


IRISYS Announces New State of the Art Equipment

August 7th, 2019
San Diego, California – IRISYS has announced additions to it’s commercial GMP manufacturing capabilities. IRISYS has long been known as the go-to CDMO for formulation development and clinical supply manufacturing. The company has been the proud single source manufacturer for multiple brand name and OTC commercial pharmaceutical drug products such as Donnatal®, an Rx product …

Continue Reading


IRISYS Announces Dr. Robert Giannini, Ph.D., As New President

June 19th, 2019
San Diego, June 16, 2019 – IRISYS is pleased to announce that Dr. Robert Giannini, Ph.D., Chief Scientific and Technical Officer at IRISYS, has been promoted to President of IRISYS. The news comes to no surprise at IRISYS, as Dr. Giannini has played an influential role in the growth of the company for the last …

Continue Reading


Director of Research and Development featured in Journal of Current Pharmaceutical Biotechnology

May 1st, 2019
IRISYS is supportive of the continuing education of our employees, as related to both their functional responsibilities and their extracurricular pursuits. Recently, our director of Research and Development, Igor Nikoulin, Ph.D., has co-authored an article titled Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors. This was …

Continue Reading


BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder

February 26th, 2019
San Diego, CA, February 26, 2019 – BioCorRx Inc. (OTCQB: BICX) (“Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it has engaged IRISYS, LLC, a contract pharmaceutical product development and manufacturing services company, for the development and manufacturing of BICX102, a multi-month sustained release naltrexone implant. …

Continue Reading


Gerald Joseph Yakatan, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who

January 17th, 2019
– Dr. Yakatan has been endorsed by Marquis Who’s Who as a leader in the pharmaceutical industry – San Diego, CA, January 17, 2019 – Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Gerald Joseph Yakatan, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Yakatan …

Continue Reading


IRISYS Chairman, CEO & Founder Recognized as “International Cooperation Ambassador” for Life Science City in China

December 21st, 2018
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRISYS, was honored by the city of Jinan in China for his contributions in facilitating international collaboration – San Diego, December 21, 2018 – Dr. Jerry Yakatan, Chairman, CEO & Founder of IRISYS, was honored by the city of Jinan in China for his contributions in facilitating international collaboration. …

Continue Reading


IRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting

July 19th, 2018
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRISYS, was honored to be the biotechnology industry representative at the invitation-only US-China Trade Relations Meeting – San Diego, July 19, 2018 – Dr. Jerry Yakatan, Chairman, CEO & Founder of IRISYS, was honored to be the biotechnology industry representative at the invitation-only US-China Trade Relations Meeting …

Continue Reading


IRISYS To Expand Drug Delivery Technology Capabilities & Services in China

July 9th, 2018
– IRISYS Announces Joint Venture with Zhejiang Yangtze River Delta Biotech Management for New Drug Delivery Systems Platform in Hangzhou – San Diego, July 9, 2018 – IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it has entered into a memorandum of understanding for a joint …

Continue Reading


IRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder

June 19th, 2018
IRISYS to discuss its customized services for international clients at the leading pharmaceutical industry event in China…  


IRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference

June 18th, 2018
Louis Scotti, Division President, will Showcase the SCOT-TUSSIN Sugar-free & Alcohol-free Medicines for Diabetic/Hypertensive Consumers…  


IRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million

August 3rd, 2017
Contract from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) Covers Ordering Period Through July 2022…  


IRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference

July 9th, 2017
More than 40 life sciences companies request meetings to learn about IRISYS’ services and expertise… 


IRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference

June 21st, 2017
IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D, introduces IRISYS to participants at “Asian Hub of Bio-business” Event… 


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme

May 10th, 2017
Dr. Yakatan to Discuss: “Where Have All the New Drugs Gone: A Model for Improving the Efficiency and Costs of Pharmaceutical R&D”… 


IRISYS Exhibits at Inaugural CPhI North America Conference

May 9th, 2017
Louis Scotti, Vice President, Business Development, leads IRISYS discussions at large pharmaceutical industry event… 


IRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value

April 20th, 2017
Award Increased to Up To $6,000,000 Over Five Years… 


IRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.

April 12th, 2017
Dr. Yakatan will hold meetings to discuss IRISYS’ customized services for international clients… 


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum

March 16th, 2017
Dr. Yakatan joins discussions with executives from pharmaceutical, biotechnology, medical device and diagnostic corporations… 


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development

February 6th, 2017
Dr. Yakatan to Direct a Discussion with FDA CDER Leaders… 


IRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials

July 15th, 2015
Valued at Up To $3,000,000 Over Five Years… 


IRISYS Receives MetroConnect Award & California Competes Tax Credit

July 10th, 2015
Helps Support IRISYS Expansion Plans in San Diego and Internationally…